William J. Plovanic, President & CEO at OBALON THERAPEUTICS INC (OBLN), bought 65,000 shares at $1.66 ($108K) on 2019-11-12, disclosed to the SEC on 2019-11-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |